Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

Macrophage Inflammatory Prostein 1alpha°¡ T ¼¼Æ÷¼ºÀå ¹× CD4, CD8 ¹ßÇö¿¡ ¹ÌÄ¡´Â ¿µÇâ

Effects of macrophage inflammatory protein-1alpha on the T cell proliferation and the expression of CD4 and CD8

ÃÖÁ¾¼±, ±è¿Àȯ,
¼Ò¼Ó »ó¼¼Á¤º¸
ÃÖÁ¾¼± (  ) - Àü³²´ëÇб³ Ä¡°ú´ëÇÐ Ä¡°ú¹æ»ç¼±Çб³½Ç
±è¿Àȯ (  ) - ÀüºÏ´ëÇб³

Abstract


Macrophage inflammatory protein (MIP)-1¥á is a cytokine which produces wide range of bioactivities such as proinflammatory, immunomodulatory, and hematopoietic modulatory actions. To determine whether MIP-1¥á acts as a negative regulator on the
functions of lymphocyte, [3H]-thymidine incorporation test and flow cytometric analysis were performed by using human tonsil T cell, human peripheral blood T cell, and murine cytolytic T lymphocyte (CTL) line CTLL-2,
@ES The results were as follow-
@EN 1. When human tonsil T lymphocytes were stimulated with anti-CD3 monoclonal antibody (mAb), rate of T cell proliferation was about four times increased. 200ng/ml of MIP-1¥á inhibited anti-CD3 mAb-mediated T cell growth as much as 60%
(P<0.05).
2. The suppression of human peripheral T cell proliferation produced by MIP-1¥á was dramatic, but variable among T cells derived from different individuals (40% ~90%).
3. MIP-1¥áinhibited the proliferation of murine CTL line CTLL-2 as much as 75% (P<0.001).
4. When the MIP-1¥á was added to human peripheral T cell, cell proportion of CD4+ helper T cell and CD+8 CTL were not noticeably affected. The expression level of CD4, not of Cd8, however, was down regulated by MIP¥á treatment (27% ~ 82%).

Å°¿öµå

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

 

µîÀçÀú³Î Á¤º¸

KCI
KoreaMed